Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Abaloparatide Acetate
Therapeutic Area : Musculoskeletal
Study Phase : Phase III
Sponsor : Endo International
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Endo Announces Licensing Agreement for Paladin Labs Inc. to Commercialize Abaloparatide in Canada
Details : Endo obtained the rights to abaloparatide-subcutaneous injection and abaloparatide-transdermal patch, a novel formulation and route of administration currently undergoing clinical development. Endo, will be responsible for all commercial activities relat...
Product Name : BA058
Product Type : Peptide
Upfront Cash : Undisclosed
May 01, 2021
Lead Product(s) : Abaloparatide Acetate
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase III
Sponsor : Endo International
Deal Size : Undisclosed
Deal Type : Licensing Agreement